A clinical study of drug Apamarga for the treatment in patients of Piles
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: K928- Other specified diseases of the digestive system
- Registration Number
- CTRI/2023/08/056827
- Lead Sponsor
- Government Ayurvedic College Patiala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Age group 18-60 years
2 Sex both male and female
3 1st and 2nd grade of haemorrhoids
Exclusion Criteria
1 Pregnancy lactating mother
2 3rd and 4th grade of haemorrhoids
3 Patients with malignancy
4 Ulcerative colitis crohns disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective parameter Grading will be done with signs symptoms of Sravi Arsha <br/ ><br>Hb TLC DLC ESR LFT RFT Digital Examination Proctoscopy levels for Haemorrhoids.Timepoint: After one month intervention of Apamarga Ghana capsule orally 15 days after stopping of medicine
- Secondary Outcome Measures
Name Time Method Subjective Parameter- Grading will be done with signs & symptoms of Sravi Arsha respectively. HB,TLC,DLC,ESR,Digital Examination,LFT RFT Proctoscopy levels for HaemorrhoidsTimepoint: After one month intervention of Apamarga Ghana capsule orally 15 days after stopping of medicine
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of Apamarga (Achyranthes aspera Linn.) are studied for hemorrhoids treatment in phase II trials?
How does Ayurvedic treatment with Apamarga compare to standard-of-care therapies for hemorrhoids in clinical effectiveness?
Are there specific biomarkers identified in CTRI/2023/08/0568/27 for predicting patient response to Apamarga in Sravi Arsha management?
What adverse events are associated with Apamarga (Achyranthes aspera Linn.) in phase II trials for digestive system disorders?
What related compounds or combination therapies with Apamarga are being explored for hemorrhoids treatment in contemporary research?